These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8757423)

  • 21. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of a nystatin pastille for treatment of denture-related oral candidiasis.
    Johnson GH; Taylor TD; Heid DW
    J Prosthet Dent; 1989 Jun; 61(6):699-703. PubMed ID: 2657027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nystatin and lidocaine pastilles for the local treatment of oral mucositis.
    Silva FC; Marto JM; Salgado A; Machado P; Silva AN; Almeida AJ
    Pharm Dev Technol; 2017 Mar; 22(2):266-274. PubMed ID: 27499389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis.
    Martins RS; Péreira ES; Lima SM; Senna MI; Mesquita RA; Santos VR
    J Oral Sci; 2002 Mar; 44(1):41-8. PubMed ID: 12058869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin versus no antifungal prophylaxis.
    Ky TQ; Park JM; McMurry KA; Tischer SM; Fitzgerald LJ; Cotiguala L
    Transpl Infect Dis; 2021 Jun; 23(3):e13559. PubMed ID: 33387388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.
    Ohnmacht GA; Phan GQ; Mavroukakis SA; Steinberg SM; Shea YR; Witebsky FG; McIntyre LS; Goodwin RS; Muehlbauer PM; Morton KE; Rogers-Freezer LJ; Seipp CA; Rosenberg SA; Marincola FM
    J Immunother; 2001; 24(2):188-92. PubMed ID: 11265777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
    Lumbreras C; Cuervas-Mons V; Jara P; del Palacio A; Turrión VS; Barrios C; Moreno E; Noriega AR; Paya CV
    J Infect Dis; 1996 Sep; 174(3):583-8. PubMed ID: 8769617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of prophylaxis against fungal infection in kidney transplant recipients.
    Guerra CM; Formica RN; Kulkarni S; Asch WS; Tichy EM
    Prog Transplant; 2015 Dec; 25(4):311-5. PubMed ID: 26645924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis.
    DeGregorio MW; Lee WM; Ries CA
    Cancer; 1982 Dec; 50(12):2780-4. PubMed ID: 6958353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection.
    Smith D; Midgley J; Gazzard B
    Int J Clin Pract; 1999; 53(5):349-52. PubMed ID: 10695098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
    Pagani JL; Chave JP; Casjka C; Glauser MP; Bille J
    J Antimicrob Chemother; 2002 Aug; 50(2):231-40. PubMed ID: 12161404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT.
    Hu L; Mao Q; Zhou P; Lv X; Hua H; Yan Z
    Oral Dis; 2019 Sep; 25(6):1573-1580. PubMed ID: 31177581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.
    Meunier F; Paesmans M; Autier P
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):196-9. PubMed ID: 7920166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome.
    Dismukes WE; Wade JS; Lee JY; Dockery BK; Hain JD
    N Engl J Med; 1990 Dec; 323(25):1717-23. PubMed ID: 2247104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
    Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
    AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation.
    Thompson PJ; Wingfield HJ; Cosgrove RF; Hughes BO; Turner-Warwick ME
    Br Med J (Clin Res Ed); 1986 Jun; 292(6537):1699-700. PubMed ID: 3089361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.